Strep A FIA Field Study, Sofia

Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial

NCT01011335 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Mol Epi GrAS in Nicaragua

NCT00170521 ·Status: TERMINATED

Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji

NCT00436891 ·Status: COMPLETED

Controlled Human Infection for Vaccination Against Streptococcus Pyogenes

NCT03361163 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Sofia SARS Antigen FIA Assay for COVID-19

NCT04953091 ·Status: UNKNOWN

An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults

NCT01018641 ·Status: COMPLETED ·Phase: PHASE1

Community-acquired Methicillin-Resistant Staphylococcus Aureus Carriage Among Athletes

NCT01148485 ·Status: COMPLETED

Human Immunity Against Staphylococcus Aureus Skin Infection

NCT02262819 ·Status: COMPLETED ·Phase: PHASE1

A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci

NCT01519492 ·Status: COMPLETED ·Phase: PHASE2

Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection

NCT00911430 ·Status: TERMINATED

Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Patients With Acute Pharyngitis.

NCT03171350 ·Status: COMPLETED ·Phase: NA

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4893 in Healthy Adult Subjects

NCT01769417 ·Status: COMPLETED ·Phase: PHASE1

Study of the Efficacy and Safety of MEDI4893

NCT02296320 ·Status: COMPLETED ·Phase: PHASE2

Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA

NCT01640886 ·Status: TERMINATED

Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

NCT00087490 ·Status: COMPLETED ·Phase: PHASE4

A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections

NCT05339802 ·Status: UNKNOWN ·Phase: PHASE2

Rapid Identification of Mycobacteria in Acid-fast Bacilli Smear-positive Respiratory Specimens

NCT00999076 ·Status: TERMINATED

Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics

NCT03162250 ·Status: COMPLETED ·Phase: PHASE1

Cefixime Clinical Trial

NCT04958122 ·Status: RECRUITING ·Phase: PHASE3

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

NCT05382312 ·Status: COMPLETED ·Phase: PHASE2

Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis

NCT03693495 ·Status: WITHDRAWN ·Phase: NA

Nasal Swab Study to Explore the Nasal Microbia

NCT02535442 ·Status: COMPLETED

TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.

NCT01170221 ·Status: COMPLETED ·Phase: PHASE3

TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

NCT01421511 ·Status: COMPLETED ·Phase: PHASE3

Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.

NCT02357966 ·Status: COMPLETED ·Phase: PHASE1/PHASE2